David Dingli
Impact in
- Hematology top 0.02%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Modeling and Simulation top 0.2%
- Mathematical Biology Tumor Growth
Papers in
- Hematology 369
- Multiple Myeloma Research and Treatments 314
- Hematopoietic Stem Cell Transplantation 37
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 162
- Co-authors
- Morie Abraham Gertz (251 shared papers)Angela A. Dispenzieri (251 shared papers)Martha Q. Lacy (251 shared papers)Shaji Kunnathu Kumar (251 shared papers)Francis K. Buadi (251 shared papers)Suzanne R. Hayman (221 shared papers)Stephen J. Russell (103 shared papers)S. Vincent Rajkumar (177 shared papers)
- Journals
- Blood (135 papers)American Journal of Hematology (70 papers)Blood Cancer Journal (53 papers)Leukemia (49 papers)Transplantation and Cellular Therapy (38 papers)
- Partner nations
- United StatesGermanyPortugal
In The Last Decade
David Dingli
630 papers receiving 24.5k citations
David Dingli's Hit Papers
Peers
Comparison fields: 5 of 149
- Hematology 13.1k
- Modeling and Simulation 1k
- Genetics 1.2k
- Molecular Biology 5.9k
- Oncology 1.2k
Countries citing papers authored by David Dingli
This map shows the geographic impact of David Dingli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dingli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dingli more than expected).
Fields of papers citing papers by David Dingli
This network shows the impact of papers produced by David Dingli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dingli. The network helps show where David Dingli may publish in the future.
Co-authors
The 25 scholars most cited alongside David Dingli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 667 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Improved survival in multiple myeloma and the impact of novel therapies Hit paper breakdown → | 2007 | 1921 |
| 2 | Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients Hit paper breakdown → | 2013 | 1150 |
| 3 | Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements Hit paper breakdown → | 2012 | 872 |
| 4 | Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines Hit paper breakdown → | 2009 | 533 |
| 5 | Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma Hit paper breakdown → | 2019 | 517 |
| 6 | Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013 Hit paper breakdown → | 2013 | 413 |
| 7 | 2007 | 321 | |
| 8 | 2003 | 287 | |
| 9 | 2017 | 271 | |
| 10 | 2009 | 265 | |
| 11 | 2014 | 241 | |
| 12 | 2018 | 217 | |
| 13 | 2012 | 211 | |
| 14 | 2005 | 205 | |
| 15 | 2006 | 205 | |
| 16 | 2020 | 197 | |
| 17 | 2006 | 186 | |
| 18 | 2011 | 184 | |
| 19 | 2013 | 182 | |
| 20 | 2011 | 171 |
About David Dingli
David Dingli is a scholar working on Hematology, Molecular Biology, Genetics, Modeling and Simulation and Genetics, having authored 667 papers that have together received 25.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (314 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (162 papers), Hematopoietic Stem Cell Transplantation (37 papers), Mathematical Biology Tumor Growth (25 papers), Virus-based gene therapy research (23 papers), Chronic Lymphocytic Leukemia Research (21 papers), CAR-T cell therapy research (19 papers) and Complement system in diseases (18 papers). The work is most often cited by research in Hematology (13.1k citations), Modeling and Simulation (1k citations), Genetics (1.2k citations), Molecular Biology (5.9k citations) and Oncology (1.2k citations). David Dingli has collaborated with scholars based in United States, Germany and Portugal. Frequent co-authors include Morie Abraham Gertz, Angela A. Dispenzieri, Martha Q. Lacy, Shaji Kunnathu Kumar, Francis K. Buadi, Suzanne R. Hayman, Stephen J. Russell, S. Vincent Rajkumar, Robert A. Kyle and John Anthony Lust. Their work appears in journals such as Blood, American Journal of Hematology, Blood Cancer Journal, Leukemia and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.